Data from EPG Health Media - Curated by Toby Galbraith - Last updated 28 May 2017

Browse related ATC

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
Monoclonal antibodies
edrecolomab
rituximab
trastuzumab
gemtuzumab
cetuximab
bevacizumab
panitumumab
catumaxomab
ofatumumab
ipilimumab
brentuximab vedotin
pertuzumab
trastuzumab emtansine
obinutuzumab
dinutuximab

Drug

Truxima▼ (Rituximab)

ATC
Orphan drug
No

Updated 16 days ago

Unituxin (Dinutuximab)

ATC
Orphan drug
Yes

Updated 25 days ago

Gazyvaro▼ (Obinutuzumab)

ATC
Orphan drug
Yes

Updated 7 months ago

Kadcyla▼ (Trastuzumab Emtansine)

ATC
Orphan drug
No

Updated 4 months ago

Removab (Catumaxomab)

ATC
Orphan drug
No

Updated 10 months ago

Vectibix (Panitumumab)

ATC
Orphan drug
No

Updated 13 days ago

MabThera (Rituximab)

ATC
Orphan drug
No

Updated 10 months ago

Yervoy (Ipilimumab)

ATC
Orphan drug
No

Updated 23 days ago

Arzerra (Ofatumumab)

ATC
Orphan drug
Yes

Updated 3 months ago

Adcetris▼ (Brentuximab vedotin)

ATC
Orphan drug
Yes

Updated 2 months ago